ProteoNic, OET Expand Agreement for Use of Recombinant Protein Technology | GenomeWeb

NEW YORK (GenomeWeb News) – ProteoNic and Oxford Expression Technologies today said they have expanded a prior agreement to grant OET a license to use ProteoNic's UNic translation enhancing elements.

OET will use the technology in its flashBAC system for third-party recombinant protein production services. As part of the deal, ProteoNic, based in Leiden, The Netherlands, will provide technical support. Financial terms include upfront payments and royalty payments of an undisclosed amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.